InvestSMART

Osteopore Limited (ASX:OSX)

ALERT: Price-sensitive ASX Announcement for OSX
Current share price for OSX : $0.005 -0.004 (-47.06%)+
Announcement
Release
27 Feb 2026 6:42PM
Price at Release
$0.009
Full Release
download
Summary
The Preliminary Financial Report for Osteopore Limited for the financial year ended 31 December 2025 reveals a challenging year with a net loss after tax of $3,722,331, an increase from the previous year's loss of $3,352,436. Despite a rise in revenue to $3,057,098, operating expenses were significantly higher due to increased investments in product development and compliance, as well as the expansion into new markets, which resulted in a comprehensive loss of $3,828,137. The company issued convertible notes to secure funding, with host debt and derivative liabilities recorded. Total current assets increased to $2,590,890, while total liabilities rose to $4,500,595, leading to a net liability position of $1,726,305. The report emphasizes maintaining financial discipline and strategic investments to support long-term growth and commercial scale.
Key Points
  • Net loss after tax was $3,722,331 in 2025.
  • Revenue increased to $3,057,098.
  • Significant rise in operating expenses due to product development and compliance.
  • Comprehensive loss was $3,828,137.
  • Convertible notes issued for funding with liabilities recorded.
  • Current assets at $2,590,890 and total liabilities at $4,500,595.
  • Emphasis on financial discipline and long-term growth support.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.